Stentome

Stentome is a medical technology company developing "smart" cardiovascular stents equipped with integrated wireless biosensors. The company's technology aims to provide real-time, non-invasive monitoring of blood flow and restenosis directly from within the implanted device. By utilizing battery-less micro-electromechanical systems (MEMS), Stentome seeks to improve long-term outcomes for patients with coronary and peripheral artery disease. This proactive monitoring approach allows for early detection of complications without the need for repeated invasive imaging procedures. The company is a spin-off from the University of California, San Francisco.